RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $109
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has maintained an Outperform rating on Tenet Healthcare (NYSE:THC) and increased the price target from $97 to $109.
February 09, 2024 | 4:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Ben Hendrix maintains an Outperform rating on Tenet Healthcare and raises the price target from $97 to $109.
The increase in price target by a reputable analyst like Ben Hendrix signals a strong confidence in Tenet Healthcare's future performance. This is likely to positively influence investor sentiment and potentially lead to a short-term increase in THC's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100